Filed with ASX · · 6 pages · English
LTR Pharma Limited has submitted an application for the quotation of securities, specifically for ordinary shares resulting from the conversion of performance rights. This announcement is categorized as a new announcement and includes information about the entity and the type of securities involved.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Appendix 2A - Application for quotation of securities Announcement Summary Entity name LTR PHARMA LIMITED Announcement Type New announcement Date of this announcement Friday November 06, 2026 The +securities to be quoted are: +Securities issued, transferred or re-classified as a result of options...
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma